Zimbabwe has sent a shipment of anti-retroviral drugs to Botswana to help address a temporary shortage in the neighboring country. The consignment, which departed Harare on October 30, 2025, comprises a mix of donated and loaned medication, with 20 percent provided as a donation and 80 percent loaned between the two governments.
Botswana had experienced delays in receiving ARVs ordered from international suppliers, creating gaps in treatment at public health facilities. Zimbabwe, which maintains sufficient stock through its national supplier NatPharm, responded quickly to prevent treatment interruptions for Botswanan patients. Anti-retroviral drugs are critical for managing HIV, and missed doses can lead to drug resistance and serious health risks.
Senior officials from both nations oversaw the handover in Harare, including Zimbabwe’s Director for Africa, Asia, and the Pacific, Spencer Mqabuko Dube, Botswana’s Ambassador Sarah S. Molosiwa, and NatPharm Managing Director Newman Madzikwa. Botswana’s government expressed deep gratitude, calling the support vital and timely. The shipment is expected to stabilize ARV availability until Botswana’s own supplies arrive.
Botswana had experienced delays in receiving ARVs ordered from international suppliers, creating gaps in treatment at public health facilities. Zimbabwe, which maintains sufficient stock through its national supplier NatPharm, responded quickly to prevent treatment interruptions for Botswanan patients. Anti-retroviral drugs are critical for managing HIV, and missed doses can lead to drug resistance and serious health risks.
Senior officials from both nations oversaw the handover in Harare, including Zimbabwe’s Director for Africa, Asia, and the Pacific, Spencer Mqabuko Dube, Botswana’s Ambassador Sarah S. Molosiwa, and NatPharm Managing Director Newman Madzikwa. Botswana’s government expressed deep gratitude, calling the support vital and timely. The shipment is expected to stabilize ARV availability until Botswana’s own supplies arrive.
